Charlotte Wang

Chang Liu

HIT-T cell paper highlighted in Cancer Cell

Response to Low Antigen Density Is Improved by HLA-Independent T-cell Receptors

CRISPR-driven CARs

CRISPR genome editing and immunotherapy – the early adopter

CRISPR gene therapy is enhancing T-cell immunotherapy treatment of cancer and treatments in people could be available within 2 to 3 years

Researchers Use CRISPR Gene-Editing Tool to Help Turn Immune Cells against Tumors

Using CRISPR to Supercharge Cancer-Killing Immune Cells

AACR 2018: An off-the-shelf, dual-targeted CAR T-cell product showed promising results in preclinical studies